BIOLINERX     Print Page  Close Window

SEC filings
F-1
BIOLINERX LTD. filed this Form F-1 on 10/02/2012
Entire Document
 
F - 53

 
 
BioLineRx Ltd.
 
NOTES TO THE FINANCIAL STATEMENTS
 
NOTE 14 – SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION (cont.)

 
f.
Sales and marketing expenses
 
   
Year ended December 31,
 
   
2009
   
2010
   
2011
 
   
NIS in thousands
 
Payroll and related expenses, including vehicles
    1,396       2,090       1,425  
Marketing
    1,400       2,258       1,428  
Overseas travel
    289       261       455  
      3,085       4,609       3,308  
 
 
 
g.
General and administrative expenses

   
Year ended December 31,
 
   
2009
   
2010
   
2011
 
   
NIS in thousands
 
Payroll and related expenses, including vehicles
    6,792       6,205       6,380  
Professional fees
    2,499       6,540       4,283  
Office supplies and telephone
    121       111       105  
Office maintenance
    117       69       72  
Depreciation
    121       109       95  
Other
    1,532       1,841       1,787  
      11,182       14,875       12,722  

 
h.
Finance income

   
Year ended December 31,
 
   
2009
   
2010
   
2011
 
   
NIS in thousands
 
Gain on change in fair value of financial assets at fair value through profit or loss
    98       -       -  
Income from interest and exchange differences on deposits
    3,830       3,056       12,730  
      3,928       3,056       12,730  

 
i.
Finance expenses

   
Year ended December 31,
 
   
2009
   
2010
   
2011
 
   
NIS in thousands
 
Exchange differences
    2,064       8,696       4,196  
Bank commissions
    100       59       67  
      2,164       8,755       4,263